Tessari Eben
Insider CIK 1867899 · KNSA Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,726 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-07 | 2026-04-08 | 2,726 | — | $0 | 23,976 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-07 | 2026-04-08 | 846 | $48.94 | $41.4K | 23,130 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,773 | — | $0 | 1,772 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 33,200 | — | $0 | 33,200 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,745 | — | $0 | 3,490 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 16,600 | — | $0 | 16,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 8,300 | — | $0 | 8,300 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-01 | 2026-04-03 | 1,756 | $48.13 | $84.5K | 21,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-01 | 2026-04-03 | 5,975 | — | $0 | 23,006 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2026-01-15 | 2026-04-03 | 365 | $24.16 | $8.8K | 17,031 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-12-15 | 2025-12-17 | 6,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-12-15 | 2025-12-17 | 12,048 | $41.56 | $500.7K | 16,666 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-12-15 | 2025-12-17 | 6,000 | $8.83 | $53.0K | 28,714 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-11-26 | 2025-12-01 | 200 | — | $0 | 46,938 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-11-26 | 2025-12-01 | 200 | $22.89 | $4.6K | 22,914 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-11-26 | 2025-12-01 | 200 | $42.89 | $8.6K | 22,714 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-11-17 | 2025-11-19 | 6,500 | — | $0 | 6,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-11-17 | 2025-11-19 | 6,500 | $8.83 | $57.4K | 35,184 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-11-17 | 2025-11-19 | 11,825 | $41.30 | $488.4K | 22,714 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-11-17 | 2025-11-19 | 645 | $40.08 | $25.9K | 34,539 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-14 | 2025-10-16 | 6,500 | — | $0 | 12,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-14 | 2025-10-16 | 6,500 | $8.83 | $57.4K | 41,052 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-14 | 2025-10-16 | 553 | $37.99 | $21.0K | 28,684 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-14 | 2025-10-16 | 11,815 | $37.65 | $444.8K | 29,237 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-29 | 2025-10-01 | 42,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-29 | 2025-10-01 | 42,000 | $17.92 | $752.6K | 76,552 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-29 | 2025-10-01 | 42,000 | $38.33 | $1.61M | 34,552 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-15 | 2025-09-17 | 6,500 | — | $0 | 19,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-15 | 2025-09-17 | 356 | $37.00 | $13.2K | 34,552 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-15 | 2025-09-17 | 6,500 | $8.83 | $57.4K | 50,952 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-15 | 2025-09-17 | 16,044 | $36.45 | $584.8K | 34,908 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-05 | 2025-09-08 | 13,389 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-05 | 2025-09-08 | 13,389 | $15.52 | $207.8K | 57,841 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-05 | 2025-09-08 | 13,389 | $35.66 | $477.5K | 44,452 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-04 | 2025-09-08 | 46,546 | — | $0 | 13,389 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-04 | 2025-09-08 | 38,725 | — | $0 | 6,249 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-04 | 2025-09-08 | 85,271 | $35.52 | $3.03M | 44,452 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-04 | 2025-09-08 | 38,725 | $15.50 | $600.2K | 83,177 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-04 | 2025-09-08 | 46,546 | $15.52 | $722.4K | 129,723 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-03 | 2025-09-03 | 15,026 | — | $0 | 44,974 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-03 | 2025-09-03 | 65 | — | $0 | 59,935 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-03 | 2025-09-03 | 15,091 | $35.50 | $535.7K | 44,452 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-03 | 2025-09-03 | 15,026 | $15.50 | $232.9K | 59,543 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-03 | 2025-09-03 | 65 | $15.52 | $1.0K | 44,517 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-02 | 2025-09-03 | 1,964 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-02 | 2025-09-03 | 1,964 | — | $0 | 45,402 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-02 | 2025-09-03 | 950 | $34.28 | $32.6K | 44,452 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 9,828 | — | $0 | 9,828 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 39,364 | — | $0 | 39,364 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,746 | — | $0 | 5,235 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,773 | — | $0 | 3,545 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 2,726 | — | $0 | 2,726 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,773 | — | $0 | 43,734 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,746 | — | $0 | 41,961 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 2,726 | — | $0 | 46,460 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-01 | 2025-09-03 | 3,022 | $33.49 | $101.2K | 43,438 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-18 | 2025-08-20 | 6,500 | — | $0 | 25,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-18 | 2025-08-20 | 100 | $34.44 | $3.4K | 40,215 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-18 | 2025-08-20 | 16,100 | $33.77 | $543.7K | 40,315 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-18 | 2025-08-20 | 6,500 | $8.83 | $57.4K | 56,415 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-05 | 2025-08-07 | 10,636 | — | $0 | 31,908 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-05 | 2025-08-07 | 25,896 | — | $0 | 39,524 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-05 | 2025-08-07 | 32,710 | — | $0 | 32,710 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-05 | 2025-08-07 | 30,444 | — | $0 | 16,694 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-05 | 2025-08-07 | 38,928 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-05 | 2025-08-07 | 25,896 | $11.97 | $310.0K | 177,893 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-05 | 2025-08-07 | 38,928 | $10.36 | $403.3K | 88,843 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-05 | 2025-08-07 | 550 | $33.90 | $18.6K | 49,915 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-05 | 2025-08-07 | 138,064 | $33.20 | $4.58M | 50,465 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-05 | 2025-08-07 | 10,636 | $10.76 | $114.4K | 188,529 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-05 | 2025-08-07 | 32,710 | $11.10 | $363.1K | 151,997 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-05 | 2025-08-07 | 30,444 | $12.97 | $394.9K | 119,287 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2025-07-15 | 2025-08-07 | 752 | $15.63 | $11.8K | 49,915 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-07-14 | 2025-07-16 | 6,500 | — | $0 | 32,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-07-14 | 2025-07-16 | 6,500 | $8.83 | $57.4K | 68,063 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-07-14 | 2025-07-16 | 18,900 | $28.72 | $542.8K | 49,163 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-16 | 2025-06-18 | 6,500 | — | $0 | 38,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-16 | 2025-06-18 | 6,500 | $8.83 | $57.4K | 78,863 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-16 | 2025-06-18 | 17,300 | $28.28 | $489.2K | 61,563 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-11 | 2025-06-11 | 45,042 | — | $0 | 38,928 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-11 | 2025-06-11 | 45,042 | $10.36 | $466.6K | 117,405 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-11 | 2025-06-11 | 45,042 | $30.51 | $1.37M | 72,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-10 | 2025-06-11 | 15,506 | — | $0 | 83,970 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-10 | 2025-06-11 | 15,506 | $30.46 | $472.3K | 72,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-10 | 2025-06-11 | 15,506 | $10.36 | $160.6K | 87,869 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-09 | 2025-06-11 | 10,319 | — | $0 | 99,476 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-09 | 2025-06-11 | 10,319 | $10.36 | $106.9K | 82,682 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-09 | 2025-06-11 | 10,319 | $30.38 | $313.5K | 72,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-19 | 2025-05-21 | 7,000 | — | $0 | 49 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-19 | 2025-05-21 | 7,000 | $3.80 | $26.6K | 84,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-05-19 | 2025-05-21 | 12,000 | $26.41 | $316.9K | 72,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 5,224 | — | $0 | 5,224 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 8,042 | — | $0 | 8,042 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 8,302 | — | $0 | 8,302 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 4,975 | — | $0 | 4,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-14 | 2025-04-16 | 7,000 | — | $0 | 7,049 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-04-14 | 2025-04-16 | 6,421 | $20.74 | $133.2K | 77,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-04-14 | 2025-04-16 | 5,579 | $20.19 | $112.6K | 83,784 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-14 | 2025-04-16 | 7,000 | $3.80 | $26.6K | 89,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-07 | 2025-04-09 | 2,726 | — | $0 | 2,726 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-07 | 2025-04-09 | 801 | $20.28 | $16.2K | 82,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-07 | 2025-04-09 | 2,726 | — | $0 | 83,164 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,746 | — | $0 | 5,235 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 39,364 | — | $0 | 39,364 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,773 | — | $0 | 3,545 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 19,657 | — | $0 | 19,657 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 9,828 | — | $0 | 9,828 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,773 | — | $0 | 79,726 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 521 | $21.77 | $11.3K | 80,951 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 513 | $21.77 | $11.2K | 80,438 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,746 | — | $0 | 81,472 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-16 | 2025-03-19 | 1,964 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-16 | 2025-03-19 | 1,964 | — | $0 | 78,530 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-03-16 | 2025-03-19 | 577 | $22.61 | $13.0K | 77,953 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-10 | 2025-03-12 | 7,000 | — | $0 | 14,049 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-10 | 2025-03-12 | 7,000 | $3.80 | $26.6K | 88,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-10 | 2025-03-12 | 12,409 | $21.06 | $261.3K | 76,566 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-02-10 | 2025-02-12 | 7,000 | — | $0 | 21,049 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-02-10 | 2025-02-12 | 14,000 | $19.57 | $274.0K | 81,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-02-10 | 2025-02-12 | 7,000 | $3.80 | $26.6K | 95,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-01-13 | 2025-01-15 | 7,000 | — | $0 | 28,049 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-01-13 | 2025-01-15 | 12,323 | $18.13 | $223.4K | 90,652 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-01-13 | 2025-01-15 | 7,000 | $3.80 | $26.6K | 102,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-01-13 | 2025-01-15 | 1,677 | $19.08 | $32.0K | 88,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-16 | 2024-12-18 | 16,017 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-16 | 2024-12-18 | 23,017 | $20.44 | $470.5K | 95,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-16 | 2024-12-18 | 16,017 | $1.59 | $25.5K | 118,992 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-11-18 | 2024-11-20 | 10,000 | — | $0 | 16,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-11-18 | 2024-11-20 | 10,000 | $1.59 | $15.9K | 119,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-11-18 | 2024-11-20 | 17,000 | $21.04 | $357.7K | 102,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-10-15 | 2024-10-17 | 10,000 | — | $0 | 26,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-10-15 | 2024-10-17 | 10,000 | $1.59 | $15.9K | 126,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-10-15 | 2024-10-17 | 17,000 | $26.87 | $456.8K | 109,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-23 | 2024-09-25 | 10,000 | — | $0 | 36,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-23 | 2024-09-25 | 10,000 | $1.59 | $15.9K | 134,475 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-09-23 | 2024-09-25 | 17,500 | $24.99 | $437.3K | 116,975 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-02 | 2024-09-04 | 1,964 | — | $0 | 1,964 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-02 | 2024-09-04 | 1,964 | — | $0 | 125,052 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-02 | 2024-09-04 | 577 | $26.74 | $15.4K | 124,475 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 2,726 | — | $0 | 5,452 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 1,773 | — | $0 | 5,318 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 36,300 | — | $0 | 36,300 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 6,981 | — | $0 | 6,981 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-01 | 2024-09-04 | 4,499 | — | $0 | 124,410 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-01 | 2024-09-04 | 1,322 | $26.74 | $35.4K | 123,088 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-08-27 | 2024-08-29 | 10,000 | — | $0 | 46,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-08-27 | 2024-08-29 | 10,000 | $1.59 | $15.9K | 137,411 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-08-27 | 2024-08-29 | 17,500 | $26.91 | $470.9K | 119,911 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-08 | 2024-04-08 | 2,726 | — | $0 | 9,573 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-08 | 2024-04-08 | 801 | $17.90 | $14.3K | 126,024 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-08 | 2024-04-08 | 2,726 | — | $0 | 126,825 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 36,300 | — | $0 | 36,300 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 5,585 | — | $0 | 5,585 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 6,981 | — | $0 | 12,299 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,773 | — | $0 | 5,318 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-01 | 2024-04-03 | 521 | $19.70 | $10.3K | 124,099 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-01 | 2024-04-03 | 1,773 | — | $0 | 124,620 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-03-01 | 2024-03-05 | 656 | — | $0 | 56,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-03-01 | 2024-03-05 | 656 | $1.59 | $1.0K | 124,036 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-03-01 | 2024-03-05 | 1,189 | $22.03 | $26.2K | 122,847 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-02 | 2023-09-06 | 1,964 | — | $0 | 3,928 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-02 | 2023-09-06 | 577 | $17.76 | $10.2K | 123,380 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-02 | 2023-09-06 | 1,964 | — | $0 | 123,957 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 7,091 | — | $0 | 7,091 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-01 | 2023-09-06 | 2,727 | — | $0 | 8,178 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 42,544 | — | $0 | 42,544 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-01 | 2023-09-06 | 801 | $17.76 | $14.2K | 121,993 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-01 | 2023-09-06 | 2,727 | — | $0 | 122,794 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-04-10 | 2023-04-11 | 2,727 | — | $0 | 8,178 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-04-10 | 2023-04-11 | 2,727 | — | $0 | 120,868 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-04-10 | 2023-04-11 | 801 | $10.71 | $8.6K | 120,067 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 42,544 | — | $0 | 42,544 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 7,091 | — | $0 | 7,091 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-20 | 2023-03-20 | 2,982 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-20 | 2023-03-20 | 2,982 | — | $0 | 119,017 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-20 | 2023-03-20 | 876 | $11.12 | $9.7K | 118,141 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-16 | 2023-03-20 | 1,964 | — | $0 | 3,928 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-16 | 2023-03-20 | 577 | $11.46 | $6.6K | 116,035 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-16 | 2023-03-20 | 1,964 | — | $0 | 116,612 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-09-02 | 2022-09-06 | 1,964 | — | $0 | 5,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-09-02 | 2022-09-06 | 1,964 | — | $0 | 115,225 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-09-02 | 2022-09-06 | 577 | $11.44 | $6.6K | 114,648 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 10,905 | — | $0 | 10,905 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 65,420 | — | $0 | 65,420 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2022-07-15 | 2022-09-06 | 1,048 | $9.56 | $10.0K | 113,261 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 10,905 | — | $0 | 10,905 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 65,420 | — | $0 | 65,420 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-21 | 2022-03-23 | 4,611 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-21 | 2022-03-23 | 4,611 | — | $0 | 113,674 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-21 | 2022-03-23 | 1,461 | $10.98 | $16.0K | 112,213 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-16 | 2022-03-18 | 1,964 | — | $0 | 5,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-16 | 2022-03-18 | 1,964 | — | $0 | 109,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-16 | 2022-03-18 | 681 | $10.13 | $6.9K | 109,063 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2022-01-15 | 2022-03-18 | 970 | $9.63 | $9.3K | 107,780 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 47,138 | — | $0 | 47,138 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 7,856 | — | $0 | 7,856 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2021-07-15 | 2022-03-18 | 868 | $11.49 | $10.0K | 106,810 | SEC↗ |